Definitive Healthcare (NASDAQ:DH) Issues Q2 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.09 for the period, compared to the consensus EPS estimate of $0.09. The company issued revenue guidance of $63.7 million, compared to the consensus revenue estimate of $62.68 million. Definitive Healthcare also updated its FY 2024 guidance to 0.320-0.340 EPS.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Morgan Stanley lowered Definitive Healthcare from an overweight rating to an equal weight rating and cut their price objective for the company from $11.50 to $9.00 in a report on Wednesday, May 8th. William Blair restated an outperform rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Stifel Nicolaus decreased their target price on Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a research report on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a research report on Thursday, May 9th. Finally, Canaccord Genuity Group cut their target price on Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a research note on Wednesday, May 8th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of Hold and an average target price of $9.56.

Definitive Healthcare Stock Down 3.9 %

Shares of NASDAQ DH traded down $0.23 on Tuesday, hitting $5.74. The company had a trading volume of 3,696,056 shares, compared to its average volume of 710,079. The company has a quick ratio of 2.30, a current ratio of 2.30 and a debt-to-equity ratio of 0.20. Definitive Healthcare has a 12-month low of $4.38 and a 12-month high of $11.97. The business has a 50 day moving average of $5.55 and a two-hundred day moving average of $7.17. The firm has a market capitalization of $676.92 million, a P/E ratio of -3.28, a PEG ratio of 4.36 and a beta of 1.30.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). The firm had revenue of $63.48 million for the quarter, compared to analyst estimates of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. As a group, equities research analysts forecast that Definitive Healthcare will post 0.1 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.